MIAS Pharma Limited, your European Partner, provides contract QP services to enable you to import and QP Release human medicinal products into Europe in a compliant manner with no significant investment in licence application, maintenance activities or office/personnel costs.
MIAS Pharma Limited holds two MIAs (Manufacturing and Importation Authorisations) to cover medicinal products for human use in EU/EEA:
1. MIA for Investigational Medicinal Products (IMPs)
The core service of MIAS Pharma is QP Batch Disposition. Whether you are carrying out a clinical trial in Europe or planning on Commercialising a product our MIAS QP’s can release your product in a compliant, time efficient and cost effective manner.
Entering the EU Market can be complex. MIAS will work with your Regulatory partner of choice to provide a QP declaration for your MAA (Marketing Authorisation Application) by validating that the API supply chain meets EMA GMP requirements.
Pharmaceutical supply chains often extend across multiple regulatory jurisdictions. MIAS can provide a dedicated QP resource to oversee the quality of the company’s supply chain and to deal with day-to-day quality-related issues arising.